Pharmacyte Biotech Inc PMCB

$0.40 +0.00 (0.25%)

Valuation

Market cap
4,317,000
Revenue TTM
$0
Net income TTM
$-19,420,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
398,400
Avg volume
252,630
Day's range
$0.36 – $0.42
Shares out
10,736,000
Stochastic %K
82%
Beta
0.78
Analysts
—
Price target
—

Price

Company profile

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer. It also develops CypCaps for pancr...

Show more

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

Industry
Biotechnology
Sector
Healthcare
Phone
917 595 2850
Website
https://pharmacyte.com
Address
3960 Howard Hughes Parkway, Suite 500, Las Vegas, United States

Latest news

Stocktwits

TwongStocks Nov 12, 9:15 PM
Tracking three stocks with reverse splits on Friday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am Friday morning. $COSM 1 for 20. Will reduce outstanding shares from approx 100.63m to approximately 5.03m. $HUBC 1 for 20. Will reduce outstanding shares from approx 19.30m to approximately 965k. $PMCB 1 for 19. Will reduce outstanding shares from approx 10.76m to approximately 566k.
0 replies
ACInvestorBlog Nov 12, 8:42 PM
$PMCB tomorrow free float will be 565K shares. This is a small bio name trading significantly below cash levels. Tomorrow with the float redution can get wild imho micro float names have been very HOT lately.
0 replies
ReversalRuler Nov 12, 8:34 PM
If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $PMCB $HUBC $COSM $ARAI
0 replies
ReversalRuler Nov 12, 6:21 PM
$PMCB $HUBC $COSM $ARAI ,,
0 replies
TwongStocks Nov 11, 6:50 PM
$PMCB Equity Corporate Actions Alert #2026 - 813 Information Regarding the Reverse Stock Split and CUSIP Number Change for PharmaCyte Biotech, Inc. (PMCB) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-813 PharmaCyte Biotech, Inc. (PMCB) will effect a one-for-nineteen (1-19) reverse split of its Common Stock. The reverse stock split will become effective on Friday, November 13, 2026. In conjunction with the reverse split, the CUSIP number will change to 71715X302.
0 replies
STACKD0E Nov 11, 5:58 PM
$PMCB 🙃 ✨️
0 replies
ACInvestorBlog Nov 11, 4:20 PM
$PMCB I would not be surprised with a close around 50c before tomorrow RS .... RS names have been very HOT
0 replies
ACInvestorBlog Nov 11, 3:36 PM
$PMCB Added for tomorrow RS... With 565K shares free float tomorrow could explode higher
0 replies